JFL Life Sciences Limited Stock

Equities

JFLLIFE

INE0LA901015

Pharmaceuticals

Market Closed - NSE India S.E. 07:43:54 2024-06-14 EDT 5-day change 1st Jan Change
41.5 INR +1.22% Intraday chart for JFL Life Sciences Limited +6.55% 0.00%

Financials

Sales 2021 328M 3.92M 5.39M Sales 2022 272M 3.25M 4.47M Capitalization 456M 5.46M 7.5M
Net income 2021 5M 59.86K 82.2K Net income 2022 27M 323K 444K EV / Sales 2021 * -
Net cash position 2021 * - 0 0 Net cash position 2022 * - 0 0 EV / Sales 2022 * -
P/E ratio 2021 *
-
P/E ratio 2022 *
-
Employees -
Yield 2021 *
-
Yield 2022 *
-
Free-Float 99%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.22%
1 week+6.55%
Current month+12.01%
1 month-7.47%
3 months+2.34%
6 months-3.60%
More quotes
1 week
38.55
Extreme 38.55
41.80
1 month
37.00
Extreme 37
44.50
Current year
36.05
Extreme 36.05
48.40
1 year
36.05
Extreme 36.05
56.00
3 years
30.10
Extreme 30.1
70.00
5 years
30.10
Extreme 30.1
70.00
10 years
30.10
Extreme 30.1
70.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 43 10-04-24
Director of Finance/CFO 41 10-04-24
Compliance Officer 31 22-11-11
Members of the board TitleAgeSince
Director/Board Member 27 22-01-17
Director/Board Member 35 22-02-09
Chief Executive Officer 43 10-04-24
More insiders
JFL Life Sciences Limited is an India-based pharmaceutical company. The Company's business segment comprises the manufacturing and selling of pharmaceutical products. The Company is engaged in producing and marketing a wide range of formulations. The Company has manufacturing facilities with trading and related activities extending to the global market. Its manufacturing facilities are located at Kerala, Bavla, Ahmedabad, Gujarat. The Company's main product categories include dry powder injections, tablets and capsules (B-Lactam) solid oral dosage form, tablet and capsules (general), and ORS. Its beta lactam dry powder injection products include Ampicillin Injection, Cefotaxime Sodium Injection -250 Mg, Cefazoline Sodium Injection and meropenem injection - 1 gm. Its beta lactam tablet and capsule products include Cefadroxil Tablets 500 mg and Cefadroxil Capsules 500 mg. Its general tablet and capsule products include Azithromycin Tablets - 500 mg and Ofloxacin Tablets - 200 mg.
More about the company
  1. Stock Market
  2. Equities
  3. JFLLIFE Stock